Can I order a chromosomal microarray myself?

Usually, no. Chromosomal microarray is a clinical genetic test that generally requires an ordering clinician, such as a geneticist, pediatrician, obstetrician, maternal-fetal medicine specialist, or qualified telehealth provider. Some labs offer patient-pay billing after a clinician orders the test, but that is different from a fully direct-to-consumer purchase.

Is chromosomal microarray covered by insurance?

It may be covered when it is medically necessary, such as for developmental delay, intellectual disability, autism with other clinical features, multiple congenital anomalies, certain prenatal ultrasound abnormalities, stillbirth, or pregnancy-loss evaluations. Prior authorization is common, and the patient may still owe deductible, coinsurance, or copay amounts.

What is included in the cost of chromosomal microarray?

The lab price may include DNA extraction, microarray testing, analysis, and a written report to the ordering clinician. It may not include the clinician visit, genetic counseling, blood draw, amniocentesis or CVS, shipping, pathology handling for tissue, insurance-administration fees, or confirmatory and family follow-up testing.

Is a cheaper chromosomal microarray less accurate?

Not necessarily. Price alone does not tell you the quality of a chromosomal microarray. Compare the exact test type, specimen type, probe coverage, what categories of findings are reported, whether genetic counselors or board-certified genetics professionals support interpretation, turnaround time, sample-failure policy, and whether follow-up parental testing is included or extra.

Chromosomal Microarray Cost: Self-Pay Testing Options

Q: How much does a chromosomal microarray cost without insurance?

Published self-pay prices are not consistent across laboratories. Hospital price-transparency files and public examples often show cash or discounted cash prices in the several-hundred to low-thousand-dollar range, while reference labs commonly require an estimate or patient-billing quote. The total can change if there are provider visit fees, genetic counseling fees, specimen collection fees, prenatal procedure fees, reflex testing, or parental follow-up testing.

Medical & affiliate disclosure: CTX Stat provides educational laboratory information and is not a substitute for professional medical advice, diagnosis, or treatment. CTX Stat may receive compensation from some outbound provider links when an affiliate program is active; provider comparisons and rankings are based on consumer fit, effective cost, access, policies, and reputation—not commission.

Quick take: chromosomal microarray cost is usually not a simple menu price. For self-pay patients in the United States, the total bill often depends on the lab used, the reason for testing, whether the sample is blood, prenatal fluid, chorionic villi, or pregnancy-loss tissue, whether insurance is billed first, and whether the order includes genetic counseling, parental follow-up, or confirmatory testing. Public hospital price-transparency examples commonly show cash prices in the several-hundred to low-thousand-dollar range for CPT 81229, but many national reference labs do not publish a single consumer price and instead provide a benefit investigation, prompt-pay quote, or good faith estimate after a clinician places or prepares the order.

Bottom line for shoppers: compare the effective total cost, not just the lab’s base charge. Ask for the test code, CPT code, specimen type, collection fee, provider or counseling fee, shipping fee, insurance-billing plan, sample-failure policy, and whether parental studies are included if a variant of uncertain significance needs clarification.

What is a chromosomal microarray?

Chromosomal microarray, often shortened to CMA, is a genetic test that looks across the genome for missing or extra pieces of chromosomal material. These changes are called copy number variants, or CNVs. Depending on the platform, a CMA may also detect long regions of homozygosity that can suggest uniparental disomy, shared ancestry, or an increased chance of recessive genetic conditions.

CMA is different from a consumer ancestry test. It is a clinical diagnostic test ordered for a medical reason and interpreted in the context of a person’s findings, family history, pregnancy history, or fetal ultrasound findings. Professional genetics literature has long supported CMA as a first-tier diagnostic test for individuals with unexplained developmental delay, intellectual disability, autism spectrum disorder with relevant clinical features, or multiple congenital anomalies. The widely cited consensus statement is available through PubMed, and ACMG/ClinGen copy-number reporting standards are summarized in this technical standards publication.

In pregnancy, CMA may be used after an invasive diagnostic procedure such as amniocentesis or chorionic villus sampling, especially when ultrasound shows fetal structural abnormalities. ACOG and the Society for Maternal-Fetal Medicine discuss prenatal microarray in their guidance on advanced genetic diagnostic tools in obstetrics and gynecology, available from ACOG.

How much does chromosomal microarray cost?

There is no single national chromosomal microarray cost. A practical self-pay range to expect is often several hundred dollars to more than $1,500 for the lab component, with total episode costs potentially higher when clinician visits, genetic counseling, prenatal procedures, specimen handling, or hospital facility billing are involved.

Why the uncertainty? Many reference laboratories use client-specific contracts or patient-billing workflows rather than one public cash price. Mayo Clinic Laboratories, for example, states that authorized users can sign in for detailed test price information and that clients without access can contact billing or customer service for pricing through its Test Prices page. Quest Diagnostics offers a self-pay price estimate process and tells patients to call if a needed test code is not included in the emailed estimate file, as described on its self-pay price estimate page. Labcorp’s patient billing page explains how patients can request a good faith estimate and resolve billing discrepancies through its billing resources.

Public hospital files can provide real-world reference points, but they should not be treated as universal prices. For example, price-transparency aggregators have shown Loma Linda University Medical Center listing chromosomal microarray with CPT 81229 and a cash price of $950 in certain settings, while Kingman Healthcare Center data have shown a congenital blood chromosomal microarray listing with a discounted cash price of $693 and a gross charge of $1,385. These figures are useful examples of how prices can vary, not guarantees of what another hospital, reference lab, insurer, or clinic will charge.

What changes the total price?

The base lab price is only one part of the bill. The total out-of-pocket cost may include:

Ordering visit: a genetics, pediatrics, neurology, maternal-fetal medicine, reproductive endocrinology, or primary care appointment.
Genetic counseling: pre-test counseling, post-test counseling, or both. Some telehealth genetics services charge separately for these services.
Specimen collection: blood draw, buccal swab kit, saliva kit, tissue handling, or pathology processing.
Prenatal procedure: amniocentesis or CVS is billed separately from the microarray itself.
Products-of-conception handling: pregnancy-loss tissue may require pathology, culture, or FFPE processing, and some labs note possible added charges for special tissue preparation.
Confirmatory testing: FISH, karyotype, targeted testing, or another method may be recommended to clarify a finding.
Parental testing: if a child or fetus has a CNV, parental studies may help determine whether it is inherited or new. Some labs include limited parental follow-up in certain circumstances; others charge separately.
Insurance administration: prior authorization, benefit investigation, deductible, coinsurance, or out-of-network billing can change the patient responsibility.

Self-pay and ordering options compared

Our comparison method is simple: focus on ordinary consumer facts that affect the final bill and experience—published price or estimate process, required ordering workflow, specimen options, turnaround time, availability notes, and likely add-on fees. We do not rank providers by compensation, and a lower advertised number is not automatically the best option if it excludes required medical services.

Option	How it usually works	Cost visibility	What to confirm before testing
Genetics clinic or specialist	A clinician evaluates the indication, orders CMA from a reference lab, and reviews results.	Often estimate-based; insurance may be billed.	Visit fee, lab name, CPT code, in-network status, prior authorization, counseling fee, and follow-up plan.
Hospital outpatient lab	Hospital or health-system lab bills for collection and/or testing, sometimes sending the sample to a reference lab.	Hospital price-transparency files may list gross and cash prices, but your final responsibility can differ.	Facility fee, professional fee, lab charge, whether the hospital or outside lab bills you, and whether the posted price includes all components.
National reference lab via your clinician	Your doctor orders a named test from Quest, Labcorp, Mayo, GeneDx, PreventionGenetics, ARUP, or another lab.	Often requires a benefits investigation, patient-pay quote, or client price lookup.	Exact test code, self-pay quote, state availability, specimen type, sample-failure policy, and whether family follow-up is included.
Telehealth genetics pathway	A virtual provider reviews eligibility, orders testing if appropriate, and discusses results.	Provider fee may be public; lab fee may be billed separately or through insurance.	Whether CMA is actually offered, not just exome or genome sequencing; provider fee; lab fee; insurance rules; and post-test support.
Direct-to-consumer purchase	Fully consumer-initiated CMA is uncommon because this is a diagnostic genetic test.	Usually not applicable for clinical CMA.	Avoid confusing ancestry or wellness DNA tests with diagnostic chromosomal microarray.

Provider examples and practical shopping notes

Quest Diagnostics. Quest lists several chromosomal microarray options, including postnatal, prenatal, products-of-conception, and oncology-related tests. Its chromosomal microarray page states that the postnatal ClariSure Oligo-SNP CMA contains more than 2.6 million probes and lists a 10–14 day turnaround for several CMA test codes, including postnatal code 16478 and prenatal code 90927. Quest also offers a Genomic Client Services phone line for clinician and patient support around genetic tests. See Quest’s chromosomal microarray analysis page and its postnatal CMA FAQ.

Labcorp. Labcorp’s Reveal SNP microarray materials describe pediatric/adult CMA, prenatal reflex testing, and products-of-conception options. Labcorp lists, for example, products-of-conception microarray with CPT 81229 and a 14–21 day turnaround, and a prenatal CVS reflex-to-microarray entry with a 9–12 day turnaround for the initial test workflow. Labcorp documents also note important limitations, including that CMA does not detect balanced rearrangements and low-level mosaicism. Review the relevant Labcorp test information, such as the POC Reveal FFPE listing and Labcorp’s SNP microarray document.

GeneDx. GeneDx lists cytogenomic testing through its provider order materials, including Chromosomal Microarray / MicroarrayDx test code 910 in its cytogenomics requisition form. GeneDx’s billing pages explain that testing may be billed to insurance, an institution, or directly to the patient through self-pay, and that patient access solutions, financial assistance, and payment plans may be available. Its patient-facing developmental delay pathway currently emphasizes exome testing through a virtual provider model and separates provider-service costs from lab-testing costs, so confirm specifically whether CMA—not exome or genome—is the test being ordered. See GeneDx billing and insurance information.

PreventionGenetics. PreventionGenetics, part of Exact Sciences, lists Whole Genome Chromosomal Microarray (CMA-ISCA), test code 2000, with blood, buccal, saliva, and tissue specimen options and a 3–5 week turnaround on its test catalog page. Its access page states that discounted pre-service prompt-pay pricing is available for all tests, but the public CMA page does not show a simple consumer price in the accessible listing. See the PreventionGenetics coverage page and the CMA-ISCA test listing.

Mayo Clinic Laboratories. Mayo Clinic Laboratories lists multiple CMA tests, including congenital blood, prenatal, and products-of-conception or stillbirth options. Mayo describes its CMA as assessing deletions, duplications, breakpoints, gene content, and regions of homozygosity, with interpretation supported by genetics professionals. Mayo’s public information directs clients to price lookup or customer service for detailed fees. See Mayo’s chromosomal microarray overview and pricing information.

Review-pattern note: public reviews for large labs often emphasize appointment access, blood-draw experience, billing, and customer service rather than the analytic quality of a rare genetic test. Use reviews to identify possible billing or access friction, but use clinical credentials, test methodology, report support, and your clinician’s experience to judge whether a CMA option is medically appropriate.

Will insurance cover chromosomal microarray?

Insurance may cover CMA when the test matches medical-necessity criteria. Common covered indications can include unexplained developmental delay, intellectual disability, congenital anomalies, certain autism evaluations, abnormal prenatal ultrasound findings, stillbirth evaluation, or products-of-conception testing after pregnancy loss. Coverage is plan-specific, and prior authorization is common for genetic testing. Even with approval, you may owe deductible, copay, or coinsurance.

Before the sample is collected, ask the ordering office and lab for:

the exact test name and test code;
CPT code, often 81229 for chromosomal microarray, though additional codes may apply;
diagnosis codes the clinician plans to submit;
whether the lab is in network for your specific plan;
whether prior authorization is required and who obtains it;
whether the lab will hold testing if your estimated out-of-pocket cost exceeds a threshold;
your self-pay price if you choose not to use insurance.

If you are uninsured or choose not to use insurance, federal No Surprises Act rules generally give self-pay patients the right to a good faith estimate for scheduled health care items and services. CMS explains these rights on its medical bill rights page. For CMA, ask whether the estimate includes the lab, blood draw, provider visit, genetic counseling, facility fee, and any expected add-on testing.

What the result may mean

A chromosomal microarray report usually falls into one of several broad categories. A pathogenic or likely pathogenic finding means the lab found a CNV believed to explain, contribute to, or materially affect the clinical question. A negative result means no reportable CNV was found under that lab’s criteria, but it does not rule out all genetic conditions. A variant of uncertain significance, or VUS, means the lab found a change but current evidence is not enough to classify it as clearly disease-causing or benign. MedlinePlus Genetics provides a consumer-friendly overview of genetic test result categories in its guide to interpreting genetic test results.

CMA is powerful, but it has limits. It generally does not detect single-letter DNA variants, many single-gene disorders, balanced translocations, inversions, Fragile X syndrome, mitochondrial DNA variants, or very low-level mosaicism. Quest’s postnatal CMA FAQ explicitly lists low-level mosaicism, balanced rearrangements, Fragile X syndrome, and single-gene disorders among categories not detected by its assay. This is why a clinician may recommend Fragile X testing, a gene panel, exome sequencing, genome sequencing, karyotype, FISH, or biochemical testing depending on the question.

How to prepare before you agree to testing

Preparation is mostly administrative and counseling-based rather than physical. Most blood, saliva, or cheek-swab collections do not require fasting. The more important steps are to make sure the right test is being ordered and the cost is understood.

Clarify the clinical question. Is the test being used for a child’s developmental evaluation, a prenatal finding, recurrent pregnancy loss, stillbirth, products of conception, or a known family CNV?
Ask why CMA is preferred. Sometimes CMA is the right first test. Other times karyotype, Fragile X testing, exome sequencing, or a targeted test may be more appropriate.
Request the exact test code. A lab may offer multiple CMA versions for postnatal blood, prenatal samples, POC tissue, FFPE tissue, cancer, or familial follow-up.
Get a written estimate. If self-pay, ask for a good faith estimate. If insured, ask for a benefits investigation and prior authorization decision when available.
Plan for results counseling. Do not assume a normal result ends the evaluation or that a VUS gives a diagnosis. Ask who will explain the report and what the next step will be for each possible result category.

When paying cash may make sense

Self-pay may be worth discussing when your deductible is high, the lab is out of network, prior authorization is denied, insurance billing would delay testing, or a lab offers a transparent prompt-pay price that is lower than your expected insurance responsibility. However, self-pay can also mean the amount does not count toward your deductible, and some labs will not switch back to insurance after testing begins. Ask these questions before choosing cash pay:

Is the self-pay amount the full amount I will owe for the lab test?
Will the ordering clinician, genetic counselor, collection site, hospital, or pathology department bill separately?
If the sample fails, is recollection or repeat testing included?
If a parental sample is needed to interpret a VUS, is that included?
If my insurance later approves the test, can billing be changed?
Will I receive an itemized receipt with CPT and diagnosis codes?

FAQs

How much does a chromosomal microarray cost without insurance?

Expect a broad range. Public examples commonly fall from several hundred dollars to more than $1,500 for the lab component, but many labs require an individualized quote. Total cost may be higher if you need a specialist visit, genetic counseling, prenatal procedure, facility billing, tissue processing, confirmatory testing, or parental follow-up.

Can I order chromosomal microarray myself?

Usually not as a pure direct-to-consumer test. CMA is a diagnostic genetic test and typically requires an ordering clinician. Some services may help connect you with a qualified provider, but confirm that the pathway offers CMA specifically and not only exome, genome, carrier screening, or ancestry testing.

Is chromosomal microarray the same as karyotype?

No. A karyotype looks at chromosomes under a microscope and can detect large changes and balanced rearrangements. CMA has higher resolution for many deletions and duplications, but it generally cannot detect balanced translocations or inversions. The best test depends on the clinical question.

Is CMA the same as exome sequencing?

No. CMA looks mainly for missing or extra chromosomal segments. Exome sequencing looks for DNA sequence changes in protein-coding genes and may also detect some copy number changes depending on the lab. A negative CMA does not rule out a single-gene condition.

Why would parental testing be needed?

If a child or fetus has a CNV, testing biological parents can show whether the change was inherited or occurred for the first time. That information may help classify the finding, estimate recurrence risk, and guide family counseling. Ask whether parental follow-up is included or billed separately.

How long do results take?

Turnaround varies by lab and specimen type. Quest lists 10–14 days for several CMA options, Labcorp examples range from about 9–12 days for certain prenatal workflows to 14–21 days for some POC testing, and PreventionGenetics lists 3–5 weeks for its CMA-ISCA test. Culture, tissue quality, confirmatory testing, or insurance holds can add time.

Will a negative CMA rule out autism or a genetic syndrome?

No. A negative CMA means the lab did not find a reportable chromosomal deletion, duplication, or related finding within the test’s limits. Some causes of autism, developmental delay, congenital differences, or genetic syndromes involve single-gene variants, repeat expansions, methylation abnormalities, mitochondrial variants, environmental factors, or causes not yet identifiable by current testing.

What should I do if the bill is higher than the estimate?

Compare the bill with the written estimate, explanation of benefits, and itemized charges. Confirm whether separate providers billed you. If you were uninsured or self-pay and the final bill is substantially higher than the good faith estimate, review CMS medical bill rights and dispute options. Also ask the lab or hospital about financial assistance, prompt-pay discounts, and payment plans.

Practical next steps

If you are comparing chromosomal microarray cost today, start with the clinician who will order and interpret the test. Ask for the exact test name, test code, CPT code, lab, specimen type, expected turnaround time, and written estimate. Then compare the total cost to the patient across options: provider fee plus lab fee plus collection or procedure fee plus any required counseling or follow-up. The least expensive option is not always the best fit, but the best option should be clear about what is included, what is excluded, and who will help you understand the result.

Sources

Educational note: This page is for general health and cost-education purposes. It cannot determine whether chromosomal microarray is appropriate for a specific person, pregnancy, or family. Genetic test selection and result interpretation should be handled with a qualified healthcare professional.